Glenn Brame joined Esperion Theraputics as Chief Technical Operations Officer in February 2023. Glenn brings over 30 years of extensive global experience in manufacturing, quality, and supply chain operations, including two multi-year technical and quality operations leadership assignments in Switzerland, one to lead the start-up and approval of a new biologic manufacturing facility in Neuchatel Switzerland and the other to lead Global Product Quality for Roche/Genentech in Basel Switzerland.
Most recently, he was Senior Vice President of Technical Operations at Zymergen where he led the synthetic biologic company’s manufacturing of advanced materials. Prior to Zymergen, Glenn was the Chief Technical Operations Officer for Portola pharmaceuticals during the successful approval and launch of Andexxa. Before Portola, he was Vice President of Supplier and Contract Manufacturing Excellence for Roche/Genentech, where he was responsible for the global transformation of quality, manufacturing, manufacturing science and technical services, and supply chain operations for both biologics and small molecule products.
During his tenure at Roche/Genentech, Glenn also served as Vice President of Global Product Quality and helped lead the successful start-up of two new biologic manufacturing sites in Oregon and Singapore. Previously, Mr. Brame was Senior Vice President of Technical Development and Operations, leading a team of 1,200 professionals for Chiron Corporation and, upon its acquisition, Novartis.
Glenn holds a Master of Business Administration from Delta State University and a Bachelor of Science in Engineering from North Carolina State University.